<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(15)</volume><submitter>Feng Y</submitter><pubmed_abstract>&lt;b>Background:&lt;/b> miR-143 is known to be downregulated in various cancer cells and tumors and generally plays a tumor-suppressor role. miR-143. However, the role of miR-143 in the mediation of the sensitivity of prostate cancer cells to abiraterone acetate remains unrevealed. &lt;b>Methods:&lt;/b> The expression levels of miRNAs were determined by miRNA microarray and quantitative real-time PCR (qRT-PCR). The protein levels were assessed by Western blot assay. Cell viability and apoptosis were respectively measured by Cell Counting Kit-8 (CCK-8) assay and flow cytometry. &lt;b>Results:&lt;/b> We identified that miR-143 was significantly downregulated in PC3-AbiR cells compared to PC3 cells. Overexpression of miR-143 promoted PC-AbiR sensitivity to abiraterone acetate in vitro and in vivo. We also rev</pubmed_abstract><journal>Journal of Cancer</journal><pagination>3652-3659</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9809307</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>miR-143 mediates abiraterone acetate resistance by regulating the JNK/Bcl-2 signaling pathway in prostate cancer.</pubmed_title><pmcid>PMC9809307</pmcid><pubmed_authors>Gao R</pubmed_authors><pubmed_authors>Cao H</pubmed_authors><pubmed_authors>Feng Y</pubmed_authors><pubmed_authors>Chen L</pubmed_authors><pubmed_authors>Wang D</pubmed_authors><pubmed_authors>Zhao W</pubmed_authors></additional><is_claimable>false</is_claimable><name>miR-143 mediates abiraterone acetate resistance by regulating the JNK/Bcl-2 signaling pathway in prostate cancer.</name><description>&lt;b>Background:&lt;/b> miR-143 is known to be downregulated in various cancer cells and tumors and generally plays a tumor-suppressor role. miR-143. However, the role of miR-143 in the mediation of the sensitivity of prostate cancer cells to abiraterone acetate remains unrevealed. &lt;b>Methods:&lt;/b> The expression levels of miRNAs were determined by miRNA microarray and quantitative real-time PCR (qRT-PCR). The protein levels were assessed by Western blot assay. Cell viability and apoptosis were respectively measured by Cell Counting Kit-8 (CCK-8) assay and flow cytometry. &lt;b>Results:&lt;/b> We identified that miR-143 was significantly downregulated in PC3-AbiR cells compared to PC3 cells. Overexpression of miR-143 promoted PC-AbiR sensitivity to abiraterone acetate in vitro and in vivo. We also rev</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-19T09:21:41.886Z</modification><creation>2025-04-19T09:21:41.886Z</creation></dates><accession>S-EPMC9809307</accession><cross_references><pubmed>36606191</pubmed><doi>10.7150/jca.78246</doi></cross_references></HashMap>